Betahistine Treatment for Vertigo

Dosage and Efficacy

• The standard dosage of betahistine for vertigo treatment is 48 mg daily, and treatment duration should typically be at least 3 months to evaluate efficacy, according to the American Academy of Otolaryngology-Head and Neck Surgery 1
• Higher doses of betahistine (144 mg/day) did not show significant improvement in vertigo control compared to lower doses (48 mg/day) or placebo in the BEMED trial, which is considered high-quality evidence 1

Clinical Considerations

• Betahistine is completely contraindicated in patients with pheochromocytoma 2
• The American Academy of Otolaryngology-Head and Neck Surgery does not make a definitive recommendation for betahistine use in controlling Ménière's disease symptoms due to conflicting evidence 1
• Common side effects of betahistine include headache, balance disorder, nausea, and upper gastrointestinal symptoms 1

Monitoring and Duration

• If oral betahistine is initiated, patients should be reassessed regularly for improvement or stabilization of symptoms and to monitor for medication intolerance or side effects 1
• If there is no improvement in vertigo symptoms after 6-9 months of treatment, it is unlikely that continued betahistine therapy will be beneficial 1

Alternative Treatments

• For acute vertigo episodes, medications with direct antiemetic and anti-vertigo effects like prochlorperazine are preferred over betahistine 3